Seo Kwon-Duk, Kang Min Jin, Lee Jae Kwang, Suh Sang Hyun, Lee Kyung-Yul
Department of Neurology, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
Institute of Health Insurance and Clinical Research, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
Ann Transl Med. 2021 Aug;9(15):1227. doi: 10.21037/atm-21-2342.
Mechanical thrombectomy (MT) of ischemic stroke was demonstrated to be effective in clinical trials and was reported to have favorable outcomes in real clinical settings since 2015. We aimed to determine the national trends of MT and compare the outcomes between the different levels of treating hospital.
We obtained data from the nationwide database from 2008 to 2017. Patients with ischemic stroke who received MT were identified using the International Classification of Disease Codes. Good outcome was defined as discharge to home, and a poor outcome was defined as cerebral hemorrhage, physical disability, or death. The study period was divided into three (off-label MT, transitional, MT period). Hospital groups where MT was performed were divided into tertiary and non-tertiary hospitals.
In MT period, 47.0% of the MT procedures were performed in non-tertiary hospitals compared with 36.1% in off-label MT period. Comparison of the 3-month mortality between patients who were treated in tertiary . non-tertiary hospitals revealed significant lower mortality in tertiary hospital through all period. The incidence of cerebral hemorrhage and physical disability did not differ between hospital groups. However, the percentage of patients discharged home was 41.4% for tertiary hospitals and 42.4% for non-tertiary hospitals, which was not statistically different in MT period (P=0.4671).
Analysis of the nationwide data confirmed that the extent of increase in MT was higher in non-tertiary hospitals than tertiary hospitals. In addition, no significant difference was revealed in the number of favorable clinical outcome between the hospital groups during MT period.
缺血性中风的机械取栓术(MT)在临床试验中已被证明是有效的,并且自2015年以来在实际临床环境中也有良好的结果报道。我们旨在确定MT的全国趋势,并比较不同级别治疗医院之间的结果。
我们从2008年至2017年的全国数据库中获取数据。使用国际疾病分类代码识别接受MT治疗的缺血性中风患者。良好结局定义为出院回家,不良结局定义为脑出血、身体残疾或死亡。研究期分为三个阶段(非适应证MT、过渡阶段、MT阶段)。进行MT的医院组分为三级医院和非三级医院。
在MT阶段,47.0%的MT手术在非三级医院进行,而在非适应证MT阶段这一比例为36.1%。比较在三级和非三级医院接受治疗的患者的3个月死亡率,发现在整个时期三级医院的死亡率显著更低。医院组之间脑出血和身体残疾的发生率没有差异。然而,三级医院出院回家的患者百分比为41.4%,非三级医院为42.4%,在MT阶段这一差异无统计学意义(P=0.4671)。
对全国数据的分析证实,非三级医院MT的增长幅度高于三级医院。此外,在MT阶段,医院组之间良好临床结局的数量没有显著差异。